14 research outputs found
Ruxolitinib impairs NK cell frequency and function in vitro and in patients with myelofibrosis
No full textRuxolitinib impairs NK cell frequency and function in vitro and in patients with myelofibrosis
No full textSpecificity of JAK-kinase inhibition determines impact on human and murine T-cell function
No full textThe JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK
No full textCryptococcal meningitis in an immunocompetent patient with primary myelofibrosis on long-term ruxolitinib: report of a rare case and review of literature
No full text
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab
No full textRisk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients
No full textNdfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells
No full text
